INOVIO PHARMACEUTICALS, INC. Available-for-sale Securities, Equity Securities, Noncurrent
INOVIO PHARMACEUTICALS, INC. (INO) had Available-for-sale Securities, Equity Securities, Noncurrent of $0 as of 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesEquitySecuritiesNoncurrent · last filed 2017-03-15
- 2016-12-31: Available-for-sale Securities, Equity Securities, Noncurrent $0.00.
- 2015-12-31: Available-for-sale Securities, Equity Securities, Noncurrent $5.97K.
- 2015-09-30: Available-for-sale Securities, Equity Securities, Noncurrent $88.90K.
- 2015-06-30: Available-for-sale Securities, Equity Securities, Noncurrent $186.50K.
| Period end | Available-for-sale Securities, Equity Securities, Noncurrent |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2015-12-31 | $5.97K 10-K · filed 2017-03-15 |
| 2015-09-30 | $88.90K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $186.50K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $259.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $550.00K 10-K · filed 2016-03-14 |
| 2014-09-30 | $591.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $881.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.41M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $717.50K 10-K · filed 2015-03-16 |
| 2013-09-30 | $244.90K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $265.50K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $266.40K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $267.20K 10-K · filed 2014-03-17 |
| 2012-09-30 | $520.60K 10-Q · filed 2012-11-07 |
| 2012-06-30 | $509.80K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $294.00K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $100.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $237.00K 10-Q · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |